IRIS
CARPAGNANO, GIOVANNA ELISIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.496
AS - Asia 4.363
EU - Europa 2.984
SA - Sud America 1.123
AF - Africa 228
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.298
SG - Singapore 1.933
BR - Brasile 858
CN - Cina 711
HK - Hong Kong 581
IT - Italia 565
RU - Federazione Russa 479
SE - Svezia 451
DE - Germania 349
VN - Vietnam 329
FR - Francia 313
FI - Finlandia 229
GB - Regno Unito 214
IN - India 177
BD - Bangladesh 134
CA - Canada 101
AR - Argentina 81
UA - Ucraina 81
IQ - Iraq 71
ID - Indonesia 68
MX - Messico 63
CI - Costa d'Avorio 62
PL - Polonia 57
ZA - Sudafrica 55
NL - Olanda 54
JP - Giappone 42
VE - Venezuela 42
EC - Ecuador 41
TR - Turchia 41
PK - Pakistan 40
CO - Colombia 36
SA - Arabia Saudita 35
AT - Austria 33
UZ - Uzbekistan 31
CZ - Repubblica Ceca 28
MA - Marocco 27
ES - Italia 26
MY - Malesia 26
IE - Irlanda 25
PH - Filippine 25
LT - Lituania 24
CL - Cile 19
EG - Egitto 19
PY - Paraguay 17
BE - Belgio 16
NP - Nepal 15
BO - Bolivia 14
JO - Giordania 14
KE - Kenya 14
TN - Tunisia 13
AE - Emirati Arabi Uniti 11
IL - Israele 10
UY - Uruguay 10
KZ - Kazakistan 9
AZ - Azerbaigian 8
DZ - Algeria 8
ET - Etiopia 7
PT - Portogallo 7
TH - Thailandia 7
GR - Grecia 6
IR - Iran 6
JM - Giamaica 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
BH - Bahrain 5
NI - Nicaragua 5
PE - Perù 5
TT - Trinidad e Tobago 5
AU - Australia 4
CH - Svizzera 4
CR - Costa Rica 4
LB - Libano 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
SC - Seychelles 3
BN - Brunei Darussalam 2
BW - Botswana 2
EE - Estonia 2
KR - Corea 2
MN - Mongolia 2
RO - Romania 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
Totale 17.182
Salva come PNG Salva come JPEG
Città #
Ashburn 1.154
Singapore 1.013
Fairfield 787
San Jose 627
Hong Kong 577
Chandler 534
Woodbridge 440
Nyköping 354
Seattle 342
Houston 311
Cambridge 287
Wilmington 254
Beijing 211
New York 201
Dallas 187
Los Angeles 186
Helsinki 182
Lauterbourg 171
Jacksonville 144
Lawrence 142
Roxbury 126
Council Bluffs 121
Ann Arbor 120
Munich 108
Des Moines 93
Ho Chi Minh City 93
São Paulo 91
Hanoi 66
Falkenstein 65
London 63
Santa Clara 63
Abidjan 62
Inglewood 62
San Diego 61
Chicago 58
Buffalo 57
Bari 56
Paris 54
Frankfurt am Main 53
Warsaw 49
Brooklyn 48
Rome 42
Jakarta 41
Tokyo 41
Orem 40
Dearborn 37
Montreal 37
Nuremberg 37
Nanjing 36
Milan 35
Boardman 34
Atlanta 32
Baghdad 32
Princeton 32
Denver 30
Dong Ket 29
Stockholm 29
Johannesburg 28
Chennai 27
Rio de Janeiro 27
Mexico City 25
Tashkent 25
Brasília 22
Poplar 22
San Francisco 22
Toronto 22
Guangzhou 21
Belo Horizonte 20
Da Nang 20
Dublin 20
Riyadh 19
Kuala Lumpur 18
Moscow 17
Naples 17
Brussels 16
Columbus 16
Manchester 16
Salt Lake City 16
Shanghai 16
Buenos Aires 15
Turku 15
Amsterdam 14
Medellín 14
Olomouc 14
Pune 14
Washington 14
Istanbul 13
Phoenix 13
Amman 12
Ankara 12
Boston 12
Charlotte 12
Haiphong 12
Hebei 12
New Delhi 12
Norwalk 12
Shenyang 12
Vienna 12
Asunción 11
Brno 11
Totale 10.957
Salva come PNG Salva come JPEG
Nome #
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 260
Application of machine learning to predict obstructive sleep apnea syndrome severity 202
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 200
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 169
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer 164
Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma 160
Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine 158
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy 142
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 136
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 135
Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA) 132
Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. 130
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 130
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 129
A European respiratory society technical standard: Exhaled biomarkers in lung disease 128
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys) 122
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients 121
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 121
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study 120
Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. 120
Exhaled inflammatory markers in aspirin-induced asthma syndrome. 120
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 116
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 116
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 115
Analysis of mitochondrial DNA alteration in new phenotype ACOS 114
Omalizumab as add-on therapy in a patient with severe asthma and OSA 113
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 113
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 113
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 112
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 112
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 111
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation 111
Predictive equations for CPAP titration in OSAS patients 110
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 109
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 108
Airway inflammation in patients affected by obstructive sleep apnea syndrome 108
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 108
Menopausal asthma: a new biological phenotype? 107
Aging and airway inflammation 106
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 105
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 105
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma 105
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 105
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 104
The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate 104
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 104
The association between dysphagia and OSA Disfagia e OSA 104
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 103
Evidence of lower oxidative stress in the air spaces of patients with reversible COPD 103
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 103
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 101
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer 100
Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy 99
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 99
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 98
Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome 98
MicroRNA expression profile during different conditions of hypoxia 98
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 98
Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate 98
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 96
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 96
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 96
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 96
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 95
Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge 94
Exhaled matrix metalloproteinase-9 in lung cancer 94
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 94
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? 93
Mitochondrial DNA alteration in obstructive sleep apnea 93
Coexistent Sarcoidosis and Tuberculosis: A Case Report 93
Correlation between nasal inflammation assessed by nasal cytology and blood neutrophil-to-lymphocyte ratio in patients with copd 92
The Role of a Polymer-Based E-Nose in the Detection of Head and Neck Cancer from Exhaled Breath 92
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 92
Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma 92
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 92
Association between exhaled nitric oxide and nasal polyposis in severe asthma 91
Effect of single session receptive music therapy on anxiety and vital parameters in hospitalized Covid-19 patients: a randomized controlled trial 90
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 90
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? 90
Advancing Care in Severe Asthma: The Art of Switching Biologics 90
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study 89
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 89
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan 89
Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19 89
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 89
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 88
Predictive machine learning models and survival analysis for covid-19 prognosis based on hematochemical parameters 88
HPV in exhaled breath condensate of lung cancer patients 87
Dyspnea perception in asthma: Role of airways inflammation, age and emotional status 87
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 87
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study 86
Exhaled breath temperature in NSCLC: Could be a new non-invasive marker? 86
Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis 86
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 86
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients 85
How strong is the association between IPF and lung cancer? An answer from airway’s DNA 85
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 84
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link? 84
Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients 84
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 84
Totale 10.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 0 0 0 0 0 155 66
2021/2022947 58 43 3 23 41 115 50 49 110 53 185 217
2022/20231.477 189 211 96 86 145 218 41 153 246 11 49 32
2023/2024708 45 125 52 55 93 172 23 25 17 19 9 73
2024/20253.528 117 59 198 115 110 369 320 340 133 203 509 1.055
2025/20267.867 1.184 349 521 810 1.045 524 1.004 255 982 810 383 0
Totale 17.783